Through activating CTLA-4, NF-ĸB signaling is blocked and IL-2 production is inhibited, so anti-tumor immune responses by tumor cytotoxic T lymphocytes and NK cells become limited [185]. This evidence concerns the gene IL2 and neoplasm.